Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Curecumin™ product (a Bioresonant Phytotherapeutic™ form of Turmeric) may be an important treatment and/or preventative for Alzheimer’s Disease.
UCLA/VA researchers found that curcumin (an active compound found in Turmeric) may help the immune system clear the brain of the amyloid beta plaques found in Alzheimer's disease patients. Recently published in the Journal of Alzheimer's Disease the findings may lead to a new approach in treating Alzheimer's disease by enhancing the natural function of the immune system using curcumin, known for its anti-inflammatory and anti-oxidant properties. According to a research study conducted at UCLA Alzheimer’s Disease Research Center, ”There is substantial in-vitro data indicating that curcumin is a promising agent in the treatment and/or prevention of AD.”
It is estimated by the Alzheimer’s Foundation of America that “Alzheimer's disease currently strikes an estimated 5.8 million Americans. It is projected that the number could more than triple to 16 million by mid-century.”
“We are particularly interested in the potential of our Curecumin™ nasal spray to deliver its benefits directly to the brain through the nasal cavity. If proven effective, we may have an efficacious, cost effective, natural treatment for the millions of Alzheimer’s sufferers, and for those who seek to prevent the disease. With 75 million aging baby boomers the potential for this product is significant." said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic™ products (a new healing modality) for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. The Company has developed several branded product lines in distribution (including the nationally recognized natural nasal spray: Flight Spray). Bioponic is focused on the production of natural products that are used to promote health and well-being. www.bioponic.com Contact: Steven M. Schorr/ CEO, Bioponic Phytoceuticals, email@example.com, ph: 808-876-1711
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company’s control that could cause actual results or events to differ materially from current expectations.